BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37315062)

  • 1. Impact of statin withdrawal on perceived and objective muscle function.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
    PLoS One; 2023; 18(6):e0281178. PubMed ID: 37315062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
    J Clin Lipidol; 2024; 18(2):e269-e284. PubMed ID: 38177036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin withdrawal and health-related quality of life in a primary cardiovascular prevention cohort.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Huth C; Bergeron J; Joanisse DR
    Qual Life Res; 2023 Jul; 32(7):1943-1954. PubMed ID: 36781811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.
    Sarzani R; Allevi M; Giulietti F; Sarnari S; Scorcella S; Di Agostini A; Turri P; Di Pentima C; Spannella F
    Nutr Metab Cardiovasc Dis; 2024 Jan; 34(1):136-144. PubMed ID: 37798232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo.
    Hlatky MA; Gonzalez PE; Manson JE; Buring JE; Lee IM; Cook NR; Mora S; Bubes V; Stone NJ
    JAMA Cardiol; 2023 Jan; 8(1):74-80. PubMed ID: 36416841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mitochondrial capacity in patients with statin-associated muscle symptoms (SAMS).
    Mangone LA; Taylor BA; Schmelzer R; Noh SG; White MC; Kwon OS; Thompson PD
    Open Heart; 2024 Feb; 11(1):. PubMed ID: 38388189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
    Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels.
    Carallo C; Capozza A; Gnasso A
    Metab Syndr Relat Disord; 2022 Dec; 20(10):567-575. PubMed ID: 36346279
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of Statin-Associated Muscle Symptoms and Its Impact on Patients Adherence and Outcomes.
    Al-Makhamreh HK; Toubasi AA; Obaid YY; Albustanji FH
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):185-191. PubMed ID: 36459061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
    Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.
    Chen W; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Future Cardiol; 2022 Jun; 18(6):461-470. PubMed ID: 35297269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
    Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
    Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial designs for statin muscle intolerance.
    Rosenson RS
    Curr Opin Lipidol; 2017 Dec; 28(6):488-494. PubMed ID: 28832369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
    Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
    J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
    Taylor BA; Thompson PD
    Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial.
    Murphy WA; Lin N; Damask A; Schwartz GG; Steg PG; Szarek M; Banerjee P; Fazio S; Manvelian G; Pordy R; Shuldiner AR; Paulding C
    Circ Genom Precis Med; 2022 Jun; 15(3):e003503. PubMed ID: 35543701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
    Iatan I; Mancini GBJ; Yeoh E; Hegele RA
    Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.